Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Shortening the paths to type 1 diabetes mellitus prevention.
Nat. Rev. Endocrinol. 17, 73–74 (2021)
The development and application of effective immunotherapies for type 1 diabetes mellitus has lagged behind our ability to identify and stage individuals in pre-clinical stages of disease. This Year in Review addresses advances in immunotherapy aimed towards prevention and our readiness to roll out screening in the broader population.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Editorial
ISSN (print) / ISBN
1759-5029
e-ISSN
1759-5037
Zeitschrift
Nature Reviews - Endocrinology
Quellenangaben
Band: 17,
Seiten: 73–74
Verlag
Nature Publishing Group
Verlagsort
New York, NY
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute for Pancreatic Beta Cell Research (IPI)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research Type 1 (IDF)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research Type 1 (IDF)